Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.94 - $1.55 $11,567 - $19,074
12,306 New
12,306 $16,000
Q1 2024

May 10, 2024

SELL
$1.27 - $2.24 $36,866 - $65,024
-29,029 Reduced 58.4%
20,678 $37,000
Q4 2023

Feb 14, 2024

SELL
$0.8 - $1.28 $30,955 - $49,528
-38,694 Reduced 43.77%
49,707 $61,000
Q3 2023

Nov 09, 2023

SELL
$0.87 - $1.84 $68,556 - $144,993
-78,801 Reduced 47.13%
88,401 $100,000
Q2 2023

Aug 09, 2023

SELL
$0.51 - $1.43 $50,013 - $140,232
-98,065 Reduced 36.97%
167,202 $153,000
Q1 2023

May 12, 2023

SELL
$0.56 - $1.15 $59,791 - $122,786
-106,771 Reduced 28.7%
265,267 $148,000
Q4 2022

Feb 09, 2023

SELL
$0.25 - $0.58 $10,168 - $23,591
-40,675 Reduced 9.86%
372,038 $215,000
Q3 2022

Nov 09, 2022

SELL
$0.3 - $0.46 $16,575 - $25,415
-55,251 Reduced 11.81%
412,713 $131,000
Q2 2022

Aug 11, 2022

BUY
$0.32 - $0.67 $21,049 - $44,072
65,780 Added 16.36%
467,964 $165,000
Q1 2022

May 12, 2022

BUY
$0.72 - $2.93 $242,483 - $986,774
336,783 Added 514.95%
402,184 $289,000
Q4 2021

Feb 11, 2022

BUY
$2.26 - $3.34 $100,723 - $148,857
44,568 Added 213.93%
65,401 $148,000
Q3 2021

Nov 12, 2021

BUY
$2.35 - $3.88 $8,152 - $13,459
3,469 Added 19.98%
20,833 $60,000
Q2 2021

Aug 10, 2021

SELL
$2.83 - $4.2 $101,959 - $151,317
-36,028 Reduced 67.48%
17,364 $66,000
Q1 2021

May 12, 2021

SELL
$2.92 - $5.06 $120,514 - $208,836
-41,272 Reduced 43.6%
53,392 $181,000
Q4 2020

Feb 10, 2021

BUY
$2.22 - $3.78 $133,386 - $227,117
60,084 Added 173.75%
94,664 $265,000
Q3 2020

Nov 12, 2020

BUY
$2.39 - $13.08 $82,646 - $452,306
34,580 New
34,580 $87,000
Q2 2020

Aug 13, 2020

SELL
$6.67 - $13.58 $560,093 - $1.14 Million
-83,972 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$4.1 - $10.24 $81,713 - $204,083
19,930 Added 31.12%
83,972 $637,000
Q4 2019

Feb 10, 2020

SELL
$3.16 - $6.73 $12,671 - $26,987
-4,010 Reduced 5.89%
64,042 $405,000
Q3 2019

Nov 12, 2019

SELL
$3.55 - $5.4 $7,188 - $10,935
-2,025 Reduced 2.89%
68,052 $267,000
Q2 2019

Aug 09, 2019

BUY
$4.1 - $8.05 $287,315 - $564,119
70,077 New
70,077 $339,000
Q1 2019

May 13, 2019

SELL
$5.41 - $8.73 $44,048 - $71,079
-8,142 Closed
0 $0
Q4 2018

Feb 06, 2019

SELL
$5.39 - $9.15 $26,443 - $44,889
-4,906 Reduced 37.6%
8,142 $45,000
Q3 2018

Nov 08, 2018

BUY
$7.44 - $10.65 $9,672 - $13,845
1,300 Added 11.07%
13,048 $115,000
Q2 2018

Aug 14, 2018

BUY
$9.15 - $11.34 $107,494 - $133,222
11,748 New
11,748 $117,000
Q4 2017

Feb 09, 2018

SELL
$14.24 - $19.59 $81,353 - $111,917
-5,713 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$13.06 - $19.67 $74,611 - $112,374
5,713
5,713 $112,000

Others Institutions Holding AKBA

About Akebia Therapeutics, Inc.


  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $349M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.